Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
eli lilly
life sciences
national
national blog main
national top stories
89bio
abbvie
abcellera
adrian krainer
alexion pharmaceuticals
alzheimer europe conference
alzheimer's disease
antibodies
asthma
astrazeneca
bain capital
beth seidenberg
biogen
biotech ipos
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cerevel therapeutics
clinical trials
convergence pharmaceuticals
coronavirus
covid-19
crispr therapeutics
cystic fibrosis
detroit blog main
detroit top stories
dicerna pharmaceuticals
drug discovery
drugs
ed kaye
What
biotech
3
×
turned
3
×
drug
abcellera
abcellera’s
alzheimer’s
announce
annual
antibodies
antibody
assessed
asthma
attention
based
beth
bio
biologics
bring
byers
capitalism
caufield
communities
companies
conference
coronavirus
develop
disrupt
drugs
enter
esmo
europe
exits
germany
helped
hosted
identified
immunologist
investment
kleiner
kpcb
Language
unset
Current search:
turned
×
biotech
×
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@techcrunch.com
8 years ago
M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF
